Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Molecular Devices is a globally recognized leader in designing, manufacturing, and marketing innovative bioanalytical measurement solutions for life sciences. Their instruments, software, and consumables are used by researchers in academic institutions, pharmaceutical companies, and biotechnology organizations to accelerate discovery and development of new therapeutics and to advance scientific understanding. Key areas of focus include microplate readers, high-content imaging systems, and other tools for cell biology, drug discovery, and bioprocessing.
Serves as the global corporate headquarters, housing key functions such as executive leadership, research and development, global marketing, operations management, and strategic planning.
State-of-the-art R&D laboratories, application development facilities, an Organoid Innovation Center, and collaborative workspaces designed to foster innovation in bioanalysis.
A customer-focused and innovative environment driven by the principles of the Danaher Business System (DBS), emphasizing continuous improvement, teamwork, and scientific excellence. Employees are encouraged to contribute to advancements in life science technology.
The headquarters is the nerve center for Molecular Devices' global operations, driving product innovation, strategic direction, and supporting its worldwide customer base in advancing scientific research.
Molecular Devices operates globally with direct sales, service, and support operations in North America, Europe, and Asia-Pacific, complemented by a network of distributors in other regions. This extensive presence ensures that researchers and scientists worldwide have access to their advanced bioanalytical technologies and expert support for applications in drug discovery, biopharma development, and life science research.
3860 N First Street
San Jose
CA
USA
Address: Molecular Devices (Shanghai) Co., Ltd., Building A, No. 258, Xinjunhuan Road, Minhang District, Shanghai 201114, P.R. China
To directly serve and expand market presence in the high-growth Asia-Pacific life sciences sector, offering localized support and expertise to researchers and biopharma companies.
Address: Molecular Devices (UK) Ltd., Winnersh Triangle, Wokingham, Berkshire, RG41 5TS, United Kingdom
To provide comprehensive support and solutions to the European market, facilitating direct engagement with key research institutions and biopharma companies in the region.
Address: Molecular Devices (Germany) GmbH, Bismarckring 3, 85521 Ottobrunn/Munich, Germany
To strengthen presence and provide dedicated support within the important DACH market, known for its strong pharmaceutical, biotech, and academic research sectors.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Molecular Devices' leadership includes:
Molecular Devices has been backed by several prominent investors over the years, including:
Molecular Devices strengthened its technology leadership with the appointment of Dr. Daniel O’Connor as Chief Technology Officer in early 2024. No other major executive team hires or departures have been widely publicized for Molecular Devices in the last 12 months.
Discover the tools Molecular Devices uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Molecular Devices commonly uses the [first name].[last name]@moleculardevices.com email format. This is a standard convention for many corporations, including those in the life sciences and technology sectors.
first.last@moleculardevices.com
Format
jane.doe@moleculardevices.com
Example
85%
Success rate
PR Newswire / Molecular Devices • January 9, 2024
Molecular Devices announced the appointment of Dr. Daniel O’Connor as its new Chief Technology Officer (CTO). Dr. O'Connor will lead the company's technology roadmap and global innovation strategy, focusing on advancing bioanalytical solutions....more
Business Wire / Molecular Devices • October 24, 2023
Molecular Devices opened its new Organoid Innovation Center in San Jose, CA. The center is dedicated to advancing 3D biology research and developing automated solutions to help researchers overcome challenges in complex cell model workflows....more
PR Newswire / Molecular Devices • July 18, 2023
Molecular Devices launched the QPix® AE Microbial Colony Picker, an automated system designed to increase the efficiency and throughput of microbial screening and selection for protein engineering and synthetic biology workflows....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Molecular Devices, are just a search away.